MX2017006709A - Agente para prevenir o mejorar sintomas causados por desequilibrio de las hormonas sexuales. - Google Patents

Agente para prevenir o mejorar sintomas causados por desequilibrio de las hormonas sexuales.

Info

Publication number
MX2017006709A
MX2017006709A MX2017006709A MX2017006709A MX2017006709A MX 2017006709 A MX2017006709 A MX 2017006709A MX 2017006709 A MX2017006709 A MX 2017006709A MX 2017006709 A MX2017006709 A MX 2017006709A MX 2017006709 A MX2017006709 A MX 2017006709A
Authority
MX
Mexico
Prior art keywords
imbalance
sex hormones
preventing
agent
improving symptoms
Prior art date
Application number
MX2017006709A
Other languages
English (en)
Inventor
Misawa Eriko
Yao Ruiqing
SAITO Marie
Tanaka Miyuki
Original Assignee
Morinaga Milk Industry Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Morinaga Milk Industry Co Ltd filed Critical Morinaga Milk Industry Co Ltd
Publication of MX2017006709A publication Critical patent/MX2017006709A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/575—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of three or more carbon atoms, e.g. cholane, cholestane, ergosterol, sitosterol
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L2/00—Non-alcoholic beverages; Dry compositions or concentrates therefor; Preparation or treatment thereof
    • A23L2/52—Adding ingredients
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/105—Plant extracts, their artificial duplicates or their derivatives
    • A23L33/11—Plant sterols or derivatives thereof, e.g. phytosterols
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/30—Dietetic or nutritional methods, e.g. for losing weight
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
    • A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • A61P5/30—Oestrogens
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2200/00—Function of food ingredients
    • A23V2200/30—Foods, ingredients or supplements having a functional effect on health

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nutrition Science (AREA)
  • Food Science & Technology (AREA)
  • Polymers & Plastics (AREA)
  • Mycology (AREA)
  • Diabetes (AREA)
  • Botany (AREA)
  • Endocrinology (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Physiology (AREA)
  • Zoology (AREA)
  • Hematology (AREA)
  • Psychiatry (AREA)
  • Pain & Pain Management (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Obesity (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

Se proporciona un medio con el cual es posible prevenir o mejorar de manera eficiente los síntomas causados por un desequilibrio de hormonas sexuales con tan poco dolor como sea posible, y que se puede tomar diariamente de manera segura. Un compuesto seleccionado del grupo que consiste de un compuesto de lofenol y un compuesto de ciclolanostano se utiliza como un ingrediente activo de un agente para prevenir o mejorar los síntomas causados por un desequilibrio de las hormonas sexuales.
MX2017006709A 2014-11-28 2015-11-27 Agente para prevenir o mejorar sintomas causados por desequilibrio de las hormonas sexuales. MX2017006709A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2014242165 2014-11-28
PCT/JP2015/083475 WO2016084956A1 (ja) 2014-11-28 2015-11-27 性ホルモンのバランスの乱れに起因する症状の予防又は改善剤

Publications (1)

Publication Number Publication Date
MX2017006709A true MX2017006709A (es) 2017-09-01

Family

ID=56074501

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2017006709A MX2017006709A (es) 2014-11-28 2015-11-27 Agente para prevenir o mejorar sintomas causados por desequilibrio de las hormonas sexuales.

Country Status (7)

Country Link
US (1) US20170319599A1 (es)
EP (1) EP3225241A4 (es)
JP (1) JP6285049B2 (es)
KR (1) KR101940433B1 (es)
CN (1) CN106999503A (es)
MX (1) MX2017006709A (es)
WO (1) WO2016084956A1 (es)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2019008484A1 (en) * 2017-07-03 2019-01-10 Suven Life Sciences Limited NEW USES OF A PURE 5-HT6 RECEPTOR ANTAGONIST
JP2019043863A (ja) * 2017-08-30 2019-03-22 森永乳業株式会社 Ｕｃｐ発現促進剤
WO2019043998A1 (ja) * 2017-08-30 2019-03-07 森永乳業株式会社 深部体温上昇用組成物
KR102040763B1 (ko) 2017-10-27 2019-11-05 한약진흥재단 호장근과 계심을 함유하는 항혈전용 조성물
KR102049440B1 (ko) 2018-01-31 2019-11-27 한약진흥재단 호장근과 계심을 함유하는 여성갱년기 증상 예방 및 개선용 조성물
KR102652335B1 (ko) 2018-03-13 2024-03-28 주식회사 케이오씨바이오 돌콩을 포함하는 여성갱년기 증상의 예방 및 개선용 조성물
WO2019188491A1 (ja) * 2018-03-29 2019-10-03 森永乳業株式会社 抗老化用組成物
WO2019188490A1 (ja) * 2018-03-29 2019-10-03 森永乳業株式会社 紫外線抵抗性向上用組成物

Family Cites Families (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5644660B2 (es) 1972-03-10 1981-10-21
JPS62277326A (ja) * 1986-05-24 1987-12-02 Zeria Shinyaku Kogyo Kk 脳機能改善剤
JPH0491026A (ja) 1990-08-06 1992-03-24 Green Cross Corp:The 植物ステロール含有脂肪乳剤
US6641847B1 (en) * 1999-06-01 2003-11-04 Ocean Spray Cranberries, Inc. Cranberry seed oil extract and compositions containing components thereof
JP2001069946A (ja) 1999-09-03 2001-03-21 Meiji Seika Kaisha Ltd 更年期障害を改善する飲食品
JP4768105B2 (ja) 2000-07-19 2011-09-07 サンスター株式会社 経口組成物
US20060039998A1 (en) * 2002-10-01 2006-02-23 Hiromu Ohnogi Remedies
CN100548317C (zh) * 2002-10-01 2009-10-14 宝生物工程株式会社 治疗药
JP4210190B2 (ja) 2003-09-29 2009-01-14 アサヒビール株式会社 ストレス緩和剤
JP2005229855A (ja) 2004-02-18 2005-09-02 Pola Chem Ind Inc 食品組成物
JP2007016013A (ja) 2005-06-10 2007-01-25 Kanebo Cosmetics Inc 更年期の皮膚改善用経口組成物
JP4095115B2 (ja) * 2005-11-25 2008-06-04 森永乳業株式会社 アロエベラ抽出物、アロエベラ抽出物の製造方法、高血糖改善剤
JP2007186483A (ja) 2006-01-10 2007-07-26 Iitekku:Kk 更年期症状を軽減する食品
CN101057854B (zh) * 2006-05-31 2010-05-12 南京大学 升麻环菠萝蜜烷型三萜类化合物在抗骨质疏松及更年期综合症的用途
JP2009232712A (ja) 2008-03-26 2009-10-15 Glico Dairy Products Co Ltd エクオール産生組成物，エクオール産生方法及びエクオール含有組成物
CN101305808A (zh) * 2008-05-30 2008-11-19 北京世纪博康医药科技有限公司 一种组合物的功能食品添加剂用途
ES2719098T3 (es) * 2008-11-19 2019-07-08 Morinaga Milk Industry Co Ltd Composiciones que comprenden un lofenol
JP6012137B2 (ja) 2010-09-30 2016-10-25 小林製薬株式会社 骨密度増加剤及び抗更年期障害剤
JP2012171933A (ja) 2011-02-23 2012-09-10 Kao Corp アロマターゼ活性化剤
JP2012031146A (ja) 2011-06-17 2012-02-16 Shiseido Co Ltd 経口更年期症状改善剤
JP6025174B2 (ja) 2013-03-28 2016-11-16 クラシエ製薬株式会社 アロマターゼ阻害剤
ITUB20155388A1 (it) * 2015-10-20 2017-04-20 Codex V Srl Insaponificabili di lipidi naturali per il trattamento e il riequilibrio della bilancia steroidica affetta da alterazione permanente

Also Published As

Publication number Publication date
EP3225241A4 (en) 2018-08-15
JPWO2016084956A1 (ja) 2017-04-27
EP3225241A1 (en) 2017-10-04
US20170319599A1 (en) 2017-11-09
CN106999503A (zh) 2017-08-01
WO2016084956A1 (ja) 2016-06-02
JP6285049B2 (ja) 2018-02-28
KR101940433B1 (ko) 2019-01-18
KR20170086120A (ko) 2017-07-25

Similar Documents

Publication Publication Date Title
MX2017006709A (es) Agente para prevenir o mejorar sintomas causados por desequilibrio de las hormonas sexuales.
PH12019550050A1 (en) Isoxazole analogs as fxr agonists and methods of use thereof
PH12016502382A1 (en) Substituted indazole compounds as irak4 inhibitors
MX2016016666A (es) Derivados de acido boronico y usos terapeuticos de los mismos.
MX2016015093A (es) Derivados de acido boronico y sus usos terapeuticos.
EA201692219A1 (ru) Способы получения противовирусных соединений
MX381417B (es) Inhibidores de glucosidasa.
MY191332A (en) Pharmaceutical composition of s-ketamine hydrochloride
MY180526A (en) Pharmaceutical composition of s-ketamine hydrochloride
MX2017001553A (es) Derivados de heterociclico opcionalmente condensados de pirimidina utiles para el tratamiento de enfermedades inflamatorias, metabolicas oncologicas y autoinmunitarias.
PH12016500356A1 (en) Nsaid and sigma receptor ligand combinations
EA201500931A1 (ru) Производные пиридин-4-ила
MX2016013894A (es) Composicion para el cuidado del cuero cabelludo.
EA201791174A1 (ru) Антимикотическое соединение
PH12017500459A1 (en) Azetidinyloxyphenylpyrrolidine compounds
CL2016002879A1 (es) Composiciones farmacéuticas para tratar enfermedades infecciosas
PH12015502282A1 (en) Alpha-2 adrenoceptor and sigma receptor ligand combinations
EA201890828A1 (ru) Оптимизированная таблетка с высокой дозой активного соединения, содержащая месалазин
PH12015502032A1 (en) Azetidinyloxyphenylpyrrolidine compounds
EA201790687A1 (ru) Хинолинкарбоксамиды для применения в лечении множественной миеломы
MX2020009966A (es) Formas de dosificacion y usos terapeuticos de la l-4-cloro quinurenina.
PH12016502544A1 (en) Pharmaceutical preparation containing entecavir as active ingredient, and preparation method therefor
MX2017006712A (es) Inhibidor de produccion de metaloproteinasa de matriz.
MX2014008336A (es) Combinacion farmacologica antihiperalgesica, antialodinica y antiinflamatoria, composiciones farmaceuticas que la contienen, y su uso para el tratamiento del dolor neuropatico.
SG11201608845PA (en) Cosmetic composition containing mentha haplocalyx as active ingredient